BG45385A3 - Метод за получаване на нафталинови производни - Google Patents

Метод за получаване на нафталинови производни

Info

Publication number
BG45385A3
BG45385A3 BG082397A BG8239786A BG45385A3 BG 45385 A3 BG45385 A3 BG 45385A3 BG 082397 A BG082397 A BG 082397A BG 8239786 A BG8239786 A BG 8239786A BG 45385 A3 BG45385 A3 BG 45385A3
Authority
BG
Bulgaria
Prior art keywords
naphthalene derivatives
level
obtaining naphthalene
obtaining
derivatives
Prior art date
Application number
BG082397A
Other languages
Bulgarian (bg)
English (en)
Inventor
Tameo Iwasaki
Kohki Takashima
Original Assignee
Tanabe Seiyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co., Ltd. filed Critical Tanabe Seiyaku Co., Ltd.
Publication of BG45385A3 publication Critical patent/BG45385A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33Polycyclic acids
    • C07C63/337Polycyclic acids with carboxyl groups bound to condensed ring systems
    • C07C63/34Polycyclic acids with carboxyl groups bound to condensed ring systems containing two condensed rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
BG082397A 1985-01-10 1986-01-09 Метод за получаване на нафталинови производни BG45385A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP309085 1985-01-10

Publications (1)

Publication Number Publication Date
BG45385A3 true BG45385A3 (bg) 1989-05-15

Family

ID=11547645

Family Applications (2)

Application Number Title Priority Date Filing Date
BG082397A BG45385A3 (bg) 1985-01-10 1986-01-09 Метод за получаване на нафталинови производни
BG073061A BG45383A3 (bg) 1985-01-10 1986-01-09 Метод за получаване на нафталинови производни

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG073061A BG45383A3 (bg) 1985-01-10 1986-01-09 Метод за получаване на нафталинови производни

Country Status (18)

Country Link
US (2) US4771072A (2)
EP (1) EP0188248B1 (2)
JP (3) JPS61267541A (2)
KR (1) KR890001884B1 (2)
CN (1) CN1006464B (2)
AT (1) ATE54441T1 (2)
AU (1) AU584153B2 (2)
BG (2) BG45385A3 (2)
DD (1) DD270529A5 (2)
DE (1) DE3672501D1 (2)
ES (2) ES8705837A1 (2)
FI (1) FI87557C (2)
HU (1) HU196737B (2)
IL (1) IL91117A0 (2)
MY (1) MY101268A (2)
NO (1) NO170760C (2)
PH (1) PH22105A (2)
PT (1) PT81814B (2)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011948A (en) * 1985-04-12 1991-04-30 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
JPS6310746A (ja) * 1986-07-01 1988-01-18 Tanabe Seiyaku Co Ltd ナフタレン誘導体
AT388372B (de) * 1987-10-08 1989-06-12 Tanabe Seiyaku Co Neue naphthalinderivate und sie enthaltende pharmazeutika
JPH01135766A (ja) * 1987-11-20 1989-05-29 Tanabe Seiyaku Co Ltd ビフェニル誘導体
PH26342A (en) * 1988-11-29 1992-04-29 Univ Texas Microbial cellulose modified during synthesis
MY105057A (en) * 1989-01-27 1994-07-30 Tanabe Seiyaku Co A process for preparing naphthalene derivatives
US5003087A (en) * 1989-02-03 1991-03-26 Tanabe Seiyaku Co., Ltd. Process for preparing a naphthalene derivative and a synthetic intermediate thereof
EP0501579A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Naphthalene lactones as inhibitors of leukotriene biosynthesis
US5227399A (en) * 1991-02-28 1993-07-13 Merck Frosst Canada, Inc. Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis
US5281720A (en) * 1991-02-28 1994-01-25 Merck Frosst Canada, Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
EP0501578A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
WO1993008155A1 (fr) * 1991-10-17 1993-04-29 Shionogi & Co., Ltd. Analogue de lignane, sa production et medicament hypolipidemiant
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
US5252599A (en) * 1992-08-27 1993-10-12 Merck Frosst Canada, Inc. Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5350744A (en) * 1992-08-27 1994-09-27 Merck Frosst Canada, Inc. Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis
US5426109A (en) * 1992-08-27 1995-06-20 Merck Frosst Canada, Inc. Phenylnaphthalene hydroxy acids
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
CA2341540A1 (en) 1998-08-25 2000-03-02 Yale University Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
CA2374260A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
CA2374263A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylether derivatives
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
CA2459017A1 (en) * 2001-08-28 2003-03-13 Sankyo Company, Limited Medicinal compositions containing angiotensin ii receptor antagonist
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
WO2015153653A1 (en) * 2014-03-31 2015-10-08 Ohio State Innovation Foundation Arylnaphthalene lactone derivatives and methods of making and using thereof
WO2017147624A1 (en) 2016-02-26 2017-08-31 Ohio State Innovation Foundation Antitumor arylnaphthalene ligand glycosides
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Also Published As

Publication number Publication date
MY101268A (en) 1991-08-17
ES550578A0 (es) 1987-05-16
PT81814A (en) 1986-02-01
ES557052A0 (es) 1987-12-16
NO855355L (no) 1986-07-11
NO170760C (no) 1992-12-02
IL91117A0 (en) 1990-03-19
FI860089L (fi) 1986-07-11
JPH0272136A (ja) 1990-03-12
PT81814B (pt) 1988-07-29
PH22105A (en) 1988-06-01
JPH0549668B2 (2) 1993-07-26
EP0188248A2 (en) 1986-07-23
FI87557B (fi) 1992-10-15
EP0188248A3 (en) 1986-12-17
FI87557C (fi) 1993-01-25
CN86100090A (zh) 1986-08-20
US5070103A (en) 1991-12-03
ATE54441T1 (de) 1990-07-15
FI860089A0 (fi) 1986-01-09
DE3672501D1 (de) 1990-08-16
AU5175185A (en) 1986-07-17
AU584153B2 (en) 1989-05-18
KR890001884B1 (ko) 1989-05-29
JPS61267541A (ja) 1986-11-27
HUT42428A (en) 1987-07-28
ES8705837A1 (es) 1987-05-16
HU196737B (en) 1989-01-30
JPH0272170A (ja) 1990-03-12
EP0188248B1 (en) 1990-07-11
CN1006464B (zh) 1990-01-17
US4771072A (en) 1988-09-13
BG45383A3 (bg) 1989-05-15
DD270529A5 (de) 1989-08-02
KR860005778A (ko) 1986-08-13
ES8801239A1 (es) 1987-12-16
NO170760B (no) 1992-08-24

Similar Documents

Publication Publication Date Title
BG45385A3 (bg) Метод за получаване на нафталинови производни
IT8026821A0 (it) Cementi solubili in acidi e metodi per impiegarli.
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
IT7927524A0 (it) Proteine purificate e procedimento per la loro preparazione.
FI860473A7 (fi) Uudet -(2-okso-2,4,5,6,7,7a -heksahydro-tieno(3,2-c)-5-pyridyyli)-fenyylietikkahappojohdannaiset, menetelmä niiden valmistamiseksi ja niiden terapeuttinen käyttö.
BE868417A (fr) Derives d'acide 1,2,3-thiadiazole-5-carboxylique leur procede de preparation et leur utilisation
FI885399A7 (fi) Uusi lääkevoide, menetelmä sen valmistamiseksi, tätä lääkevoidetta käy ttämällä aikaansaadut käyttömuodot sekä niiden valmistus
RU94029667A (ru) ПРОИЗВОДНЫЕ 11β -БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ЛЕКАРСТВЕННЫЕ СРЕДСТВА
FR2656214B1 (fr) Cadre dynamique d'osteosynthese du rachis.
FI892052A7 (fi) Happoadditiosuoloja ja menetelmä niiden valmistamiseksi
IT1109095B (it) Acidi 1.3 ditietan 2 carbossilici e procedimento per la loro preparazione
FI874676L (fi) Menetelmä anti-HIV:n määrittämiseksi, tarvikkeet sitä varten ja niiden käyttö tässä menetelmässä
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
BG44379A3 (en) Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives
FR2542013B1 (fr) Procede de preparation et de conservation d'un hydrolysat proteinique utile notamment dans le domaine agro-alimentaire
FI842538A7 (fi) Bisyklo(3.2.1)oktaanikarboksyylihappojohdannaiset, niiden valmist usmenetelmä sekä niiden terapeuttinen käyttö.
IT1188557B (it) Acidi 8-osso-2-ossa-1-azabiciclo (4.2.0)ottano-3-carbossilici
FI874875A7 (fi) Uusia 2,6-diamino-3 -halogeeenibentsyylipyridiinejä ja menetelmä niiden valmistamiseksi sekä niiden käyttö lääkevalmisteissa.
IT8722055A0 (it) Procedimento per la preparazione di idantoine 5-ariliden e alchilidensostituite.
IS1374B6 (is) Ný benzamíð, aðferð við gerð þeirra og notkun þeirra á sviði lyfja
BG44874A3 (bg) Метод за получаване на кондензирани аs-триазини
FI842742A7 (fi) 15,16-metyleeni-17 -pregna-4,6-dieeni- 21-karboksyyli-happosuolat, niitä sisältävät farmaseuttiset valmisteetsekä menetelmä niiden valmistamiseksi.
BG94501A (bg) Метод за получаване на 10-дихидро-10-деоксо-11-азаеритронолиди а
BG46747A3 (bg) Метод за получаване на 1,5- бензотиазепинови производни